Novel Biomarkers 2017-03-03T15:50:07+00:00

Clinical Trials

January 22, 2013

A Natural History Study of Novel Biomarkers in Pulmonary Arterial Hypertension

  • Study Sponsor: National Institutes of Health
  • Start Date: 01/2013
  • End Date: 01/2023
  • Design: Background treatment allowed
  • Age range (years): from 18 to 99
  • Type of PH
    • All PAH (Group 1 PH)
    • IPAH
    • Heritable – APAH
    • CTD – APAH
    • CHD – APAH
    • PoPH – APAH
    • Toxic – APAH
    • HIV – APAH
    • Hem – APAH
  • Study Duration for individual patient: Indefinite duration
  • Contact: Bonnie Harper at PAHresearch@nih.gov
  • Listing on clinicaltrials.gov